jdm

Journal of Diabetes & Metabolism

ISSN - 2155-6156

Mini Review - (2023) Volume 14, Issue 5

Analysing Cardiovascular Risk and the Incidence of Peripheral Artery Disease in People with Type 2 Diabetes Using the Ankle-Brachial Index

Giviaeni Santore*
 
*Correspondence: Giviaeni Santore, Department of Medicine - DIMED, University of Padua, Italy, Email:

Author info »

Abstract

Background and aims: Type 2 diabetes mellitus (T2DM) is a significant gamble factor for fringe supply route sickness (Cushion). The Ankle- Brachial Index (ABI) was found to be linked to a higher mortality and cardiovascular (CV) risk. The primary objectives of this study were to determine the prevalence of PAD in a T2DM population and to examine the connection between PAD and the CUORE Project score (CPS) calculated CV risk. Also investigated was the connection between the ABI, the main risk factors for PAD, and T2DM complications.

Methods and results: Two hundred patients were enrolled consecutively. In this population, 17% of the people had PAD. The group with a pathological ABI had a higher CV risk (p = 0.0712) than the group with a normal ABI. Hemoglobin with glycation (r = 0.1591; total cholesterol (r = 0.1958; p = 0.0244), and LDL cholesterol (r = 0.1708; p = 0.0054; systolic blood pressure (r = 0.1523; p = 0.0156; p = 0.0313) had a negative and significant correlation with the left ABI. The group with a pathological ABI had a significantly higher rate of diabetic retinopathy (p = 0.0316).

Conclusions: The data indicate a high prevalence of PAD among T2DM patients. The CPS confirmed that patients with pathological ABI tend to have a higher risk of cardiovascular disease. The findings emphasize the significance of a precise CV assessment, which includes calculating a person's CPS and measuring their ABI, in order to more precisely identify individuals who are at risk for PAD, particularly T2DM patients.

Keywords

Peripheral artery disease; Type 2 diabetes; Ankle-brachial index; Cardiovascular risk; CUORE Project Conceptual

Introduction

Cardiovascular disease is a major concern for people with type 2 diabetes, and it is a leading cause of morbidity and mortality in this population. In addition to heart disease, people with diabetes are also at increased risk for peripheral artery disease (PAD), a condition that affects the blood vessels outside of the heart and brain. Recent research has explored the link between cardiovascular risk and the incidence of PAD in people with type 2 diabetes. Studies have found that individuals with higher cardiovascular risk scores are more likely to develop PAD, and that early intervention to reduce risk factors such as high blood pressure and high cholesterol can help prevent the development of this condition. Regular monitoring and management of cardiovascular risk factors is essential for people with type 2 diabetes to prevent complications such as PAD and improve overall health outcomes [1- 4]. Type 2 diabetes mellitus (T2DM) is a significant gamble factor for fringe supply route sickness (Cushion). The Ankle-Brachial Index (ABI) was found to be linked to a higher mortality and cardiovascular (CV) risk. The primary objectives of this study were to determine the prevalence of PAD in a T2DM population and to examine the connection between PAD and the CUORE Project score (CPS) calculated CV risk. Also investigated was the connection between the ABI, the main risk factors for PAD, and T2DM complications [5, 6].

Methods

To lay out the pervasiveness of Cushion in our T2DM populace, we enlisted 200 back to back patients somewhere in the range of 35 and 70 years of age. We considered patients with known T2DM who consistently went to the Diabetes Center of the ULSS 6 Region Wellbeing Unit in Padua (north-east Italy) [7].

The study was carried out in accordance with the Declaration of Helsinki's Standards of Good Clinical Practice. The local Ethics Committee approved the study protocol (study No. 3965/U16/16).

We estimated the left and right ABI in all patients and recorded every patient's age and sex, anthropometric information (level, weight and BMI), smoking propensities (smoker, past smoker >12 months, non-smoker), history of CV occasions, pulse and additionally antihypertensive therapy, anti-inflamatory medicine consumption, length of T2DM, any vascular entanglements (instances of neuropathy, nephropathy and retinopathy were gotten from patients' clinical records), glycated hemoglobin level, and blood lipid profile. Microalbuminuria was used to measure nephropathy, the Deep Breathing test was used to measure neuropathy, fundus oculi were used to look for retinopathy, and echo color Doppler was used to look for carotid stenosis [s].

CUORE Task Score (CPS)

The CPS is an Italian framework for anticipating CV gamble, characterized as the likelihood of encountering a first significant CV occasion in the following 10 years. The score can be obtained by using risk charts or by figuring out a person's risk on the cuore.iss.it website, which was used for this study because it was more accurate.

Patients must be between 35 and 69 years old and have never had a major cardiovascular event for the score to be calculated. The score ought not be utilized for pregnant ladies, or on the other hand assuming a patient has specific gamble factors -, for example, pulse or blood lipids that are excessively high or excessively low (SBP <90 mmHg or >200 mmHg, complete cholesterol <130 mg/dL or >320 mg/dL). Consequently, the CPS was not determined for 27 of the 200 patients selected for this review [9]. Individual gamble, regarding the CPS, is determined thinking about the accompanying elements: sex, age, diabetes, cigarette smoking, all out cholesterol, HDL cholesterol, systolic circulatory strain and antihypertensive treatment.

In the Italian population, the CPS has proven to be more suitable than other CV risk prediction methods. Giampaoli et al. found that the Framingham score misjudges the gamble, while the European SCORE thinks about mortality as an endpoint, consequently overlooking non-deadly CV occasions [s].

Results

Characteristics of the patients

As can be seen in Table 1, the mean ABI was 1.12-0.17 on the right side and 1.12-0.18 on the left. Of the 200 patients enlisted, the ABI was ordinary in 83% (166 subjects), while 17% (34 subjects) had an obsessive ABI: The ABI was 0.90 in 4.5 percent (nine patients) and 1.30 in 12.5 percent (25 patients).

Empty Cell Right ABI (mean ± SD) Left ABI (mean ± SD) pa
All patients (n = 200) 1.12 ± 0.17 1.12 ± 0.18 0.4955
Patients with no history of cardiovascular events (n = 173) 1.10 ± 0.17 1.10 ± 0.14 0.1454

Table 1:ABI values (measured on the right and left) in the cohort of patients as a whole, and in those with no history of cardiovascular events.

Association between the ABI and the CUORE project score

We excluded the 27 patients who had previously experienced a cardiovascular event in order to investigate the possibility of a link between the ABI values and the CV risk that was calculated using CPS. Table 1 displays the mean right and left ABI values for this subset of diabetic patients.

Association between PAD and cardiovascular risk factors

As a secondary objective, we investigated the connection between PAD in our T2DM patient population and some of the most well-established cardiovascular risk factors, such as smoking, arterial hypertension, dyslipidemia, obesity, and age.

The means of the two groups with a normal as opposed to a pathological ABI were significantly different when compared using the t-test for independent data in terms of: body weight (p = 0.0272), LDL cholesterol (p = 0.0293), and total cholesterol (p = 0.0074). Triglycerides, HDL cholesterol, blood pressure, and smoking habits were not comparable between the two groups. Other known PAD risk factors in patients with T2DM, such as glycated hemoglobin and duration of diabetes, did not differ significantly between the two groups (Table 2).


Empty Cell
Right ABI (mean ± SD) Left ABI (mean ± SD) pa
All patients (n = 200) 1.12 ± 0.17 1.12 ± 0.18 0.4955
Patients with no history of cardiovascular events (n = 173) 1.10 ± 0.17 1.10 ± 0.14 0.1454

Table 2: shows the clinical and metabolic features of the total sample of patients recruited for the study (n=200), divided according to their normal vs pathological ABI.

Association between T2DM complications and PAD Every patient in our sample had their microvascular and macrovascular diabetes complications evaluated. In terms of neuropathy, nephropathy, or carotid stenosis, the differences in mean values between the two groups of patients with a normal ABI and a pathological ABI were not statistically significant. Diabetic retinopathy was the only significant difference (p = 0.0316).

Discussion

This study found that our T2DM population had a PAD prevalence of 17%, which is consistent with findings from international studies and about three times higher than the general population's PAD prevalence.

As far as anyone is concerned, hardly any investigations have been led on the pervasiveness of Cushion among Italian individuals with T2DM. Faglia et al.'s study in 2005 recognized a commonness of 21% - marginally higher than that of the current review. These figures propose that the essential avoidance of hazard factors for the beginning of Cushion actually should be strengthened with an end goal to decrease the infection's pervasiveness [11].

PAD can be diagnosed when the ABI is less than 0.90, according to the most recent guidelines from the European Society of Cardiology (ESC) and the American College of Cardiology/American Heart Association (ACC/AHA). Although values greater than 1.40 are regarded as pathological and linked to an increase in mortality and CV risk, there is still some debate regarding them: a few creators judge this slice off to be non-demonstrative for Cushion, as it is connected to the presence of calcifications and an ensuing solidifying of the tunica media in the vessels [12].

According to a recent meta-analysis, individuals with an abnormally low or high ABI had similar relative risks of CV-related mortality, all-cause mortality, and major adverse CV events. The Strong Heart Study of 2004 found that people with a high ABI were nearly twice as likely to be diabetic as those with a low ABI. This suggests that the former are by no means uncommon and that a high ABI may have a greater impact on health than a low ABI. The most significant risk factor for high ABI values is diabetes mellitus [13]. A U-shaped relationship was found between the ABI, a non-invasive measure of PAD, and mortality risk because the relationship between a high ABI and mortality was nearly identical to that between a low ABI and mortality. A subsequent study demonstrated that individuals with a high ABI were significantly more likely than those with a normal ABI to develop neuropathy, foot ulcers, congestive heart failure, and stroke. Distal symmetrical neuropathy (DSN) has been shown to play a role in the pathogenesis of arterial calcification and contributes to the explanation of the distal distribution of calcification observed in diabetes [14]. A high ABI is also closely linked to arterial calcification. Diabetic foot can be made worse by PAD and DSN: Any microtrauma to the lower limbs that is combined with an increased pain threshold and tissue hypoperfusion favours superinfection, which can result in gangrene and limb amputation. In fact, 80%–90% of patients with acute Charcot's disease or a history of it can be seen with arterial calcification on radiographs, more than any other clinical group studied. Patients with T2DM and PAD also have a higher mortality rate than non-diabetic patients (51.7% vs. 25.6%), and the need for major amputations is five to ten times greater in diabetic patients with PAD than in non-diabetic patients [15,16].

Conclusion

This study sheds light on a problem that has not received sufficient attention in recent years: the prevalence of PAD in T2DM patients and the significance of early detection for reducing a patient's overall CV risk and treating or preventing complications. In the future, it would be beneficial to expand the studied series in order to fine-tune a threshold value that can be considered pathological and better define the meaning of a high ABI (1.3) on both the diagnostic and prognostic fronts.

Acknowledgements

None

Conflict of Interest

None

References

  1. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. (1998)Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47: 1643-1649.
  2. Indexed at, Google Scholar, Crossref

  3. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
  4. Indexed at, Google Scholar, Crossref

  5. Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diab Rep 9: 193-199.
  6. Indexed at, Google Scholar, Crossref

  7. Ausk KJ, Boyko EJ, Ioannou GN (2010) Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes care 33:1179-1185.
  8. Indexed at, Google Scholar, Crossref

  9. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L (2002) Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabetic Med: J Brit Diabetic Assoc 19: 470-475.
  10. Indexed at, Google Scholar, Crossref

  11. Barnoy S, Volfin-Pruss D, Ehrenfeld M, Kushnir T (2011) Self-epistemic authority and nurses' reactions to medical information that is retrieved from Internet sites of different credibility. Nurs Health Sci 13: 366-370.
  12. Indexed at, Google Scholar, Crossref

  13. Benetoli A, Chen TF, Aslani P (2018) How patients' use of social media impacts their interactions with healthcare professionals. Patient Educ Counsel 101: 439-444.
  14. Indexed at, Google Scholar, Crossref

  15. Broom A (2005) Virtually healthy: the impact of internet use on disease experience and the doctor-patient relationship. Qual Health Res 15: 325-345.
  16. Indexed at, Google Scholar, Crossref

  17. Collins H, Evans R, Gorman M (2007) Trading zones and interactional expertise. Stud Hist Philos Sci 38: 657-666.
  18. Indexed at, Google Scholar

  19. Collins H, Evans R, Gorman ME (2019) Trading zone revisited. The Third Wave in Science and Technology Studies 275-281.
  20. Indexed at, Google Scholar

  21. Lykkesfeldt J, Poulsen HE (2010) Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br J Nutr 103(9): 1251-125.9
  22. Indexed at, Google Scholar, Crossref

  23. Mason SA, Keske MA, Wadley GD (2021) Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 44(2): 618-630.
  24. Indexed at, Google Scholar, Crossref

  25. Sargeant LA, Wareham NJ, Bingham S, Day NE, Luben RN, et al. (2000) Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care 23(6): 726-732.
  26. Indexed at, Google Scholar, Crossref

  27. Gillis K, Stevens KK, Bell E, et al. (2018) Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clinical Kidney Journal11(4): 532-539
  28. Indexed at, Google Scholar, Crossref

  29. Takahashi N, Morimoto S, Okigaki M, Seo M, Someya K, et al. (2011) Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrol Dial Transplant 26: 1252-1257.
  30. sIndexed at, Google Scholar, Crossref

  31. Fox NJ, Ward KJ, O'Rourke AJ (2005) The “expert patient”: empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. Soc Sci Med 60: 1299-1309.
  32. Indexed at, Google Scholar, Crossref

Author Info

Giviaeni Santore*
 
Department of Medicine - DIMED, University of Padua, Italy
 

Citation: Giviaeni Santore. Analysing Cardiovascular Risk and the Incidence of Peripheral Artery Disease in People with Type 2 Diabetes Using the Ankle-Brachial Index. J Diabetes Metab, 2023, 14(5): 1003.

Received: 01-May-2023, Manuscript No. jdm-23-24043; Editor assigned: 04-May-2023, Pre QC No. jdm-23-24043(PQ); Reviewed: 18-May-2023, QC No. jdm-23-24043; Revised: 25-May-2023, Manuscript No. jdm-23-24043(R); Published: 31-May-2023, DOI: 10.35248/2155-6156.10001003

Copyright: © 2023 Santore G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.